Acessibilidade
A+
A-
Institucional

Climate change

Em Compromissos:

/ Planeta

20 - Reduce absolute GHG emissions (scope 1 and 2) within the level below 1.5 oC, using 2021 as the base year

Compared to 2022, there was a 27.16% reduction in scope 1 and scope 2 emissions. This reduction was mainly due to the actions taken in transport between the Distribution Centers and the Pharmacies (page 96), and the increased consumption of energy from renewable sources.
Leia mais

21 - Engage suppliers responsible for emissions from purchased goods and services (category 1) to have science-based targets by 2030

In 2024, we will implement a pilot project with suppliers responsible for emissions from purchased goods and services to engage them in decarbonization strategies.
Leia mais

22 - Reach 100% of the operation supplied with renewable energy

We reached 72% of operations supplied with renewable energy.
Leia mais

Em Temas Materiais:

Climate action

The Company’s efforts to reduce GHG emissions and optimize energy use in a sustainable manner.

Leia mais

Em Global Reporting Initiative:

/ Topic Standards - Economic - Economic Performance

GRI 201-2

Over the past few years, we have made significant progress on the ESG agenda and its integration into the routine analysis of scenarios, trends and factors that may positively or negatively impact our business. Climate-related risks are embedded in the Company’s Risk Matrix and are continuously monitored and evaluated by the Sustainability Committee and the […]
Leia mais

/ Tópicos materiais - Environment - Energy

GRI 302-1

To calculate energy consumption from non-renewable sources, we consider the percentage of non-renewable electricity from utilities, using values from the National Energy Balance (BEN) for this calculation. Then, we add the consumption of non-renewable fuels (aviation kerosene, gasoline, diesel, and LPG). To calculate energy consumption from renewable sources, we consider the percentage of renewable electricity […]
Leia mais

GRI 302-2

We do not control energy consumption outside the organization. Therefore, this information is unavailable.
Leia mais

GRI 302-3

The Company’s energy intensity ratio is calculated based on the total energy consumption within the organization for the year, including the consumption of fuels and electricity. The denominator used is the built area, in square meters, of pharmacies, distribution centers, and the campus (office). We had a reduction in the ratio between 2022 and 2023 […]
Leia mais

GRI 302-4

As a result of our energy efficiency actions, in 2023, we had an average 18% reduction in the total electricity consumption of the network of pharmacies. However, there was no overall reduction in electricity consumption from 2022 to 2023, a reflection of the expansion and growth of our operation. Two methods were employed to calculate […]
Leia mais

GRI 302-5

Our approach to energy efficiency is based on two main fronts of action: • initiatives to reduce consumption at facilities, through the modernization of physical infrastructure and equipment, and awareness programs for our people and customers; • actions focused on increasing energy consumption from renewable sources. We maintain 100% of our lighting with LED bulbs […]
Leia mais

/ Tópicos materiais - Environment - Emissions

GRI 305-1

Check out the quantitative data on Scope 1 emissions from RD Saúde. Information on Scopes 2 and 3 emissions can be verified in disclosure 305-2 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs […]
Leia mais

GRI 305-2

Check out the quantitative data on Scope 2 emissions from RD Saúde. Information on Scopes 1 and 3 emissions can be verified in disclosures 305-1 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs […]
Leia mais

GRI 305-3

Check out the quantitative data on Scope 3 emissions from RD Saúde. Information about Scopes 1 and 2 emissions can be verified in disclosures 305-1 and 305-2. Also check out qualitative information about our climate journey in the TCFD tab of this panel. Emissão biogênica por escopo (tCO2e)1 2021 2022 2023 Escopo 1 24.596,19 29.051,29 […]
Leia mais

GRI 305-4

The intensity of emissions was 3.86 tCO2/t of products in 2023, which accounts for a 19% reduction compared to 2022. Notas: 1. Includes the categories: waste generated in operations, business travel, transport and distribution (downstream), use of goods and services sold, end-of-life treatment of products sold and investments. 2. Drugs, over-the-counter (OTC) drugs, and perfumery […]
Leia mais

GRI 305-5

Since 2021, we have been making progress in the use of electric trucks for B2B deliveries, i.e. the route from Distribution Centers to pharmacies. In addition, part of the fleet has switched to S10 diesel, a less carbon-intensive fuel. We continue working to strengthen the partnerships with last mile delivery companies to increase the use […]
Leia mais

Em SASB:

/ Retail energy management

HC-DR-130a.1

1) 1.,216,235.43 GJ2) 40%,3) 72.57%
Leia mais

Em TCFD:

/ Governance

a) Describe the Board's oversight of climate-related risks and opportunities.

The Board of Directors is supported by the Sustainability Committee, which meets at least ten times a year to assess the progress of actions and performance of our sustainability strategy—including our climate change mitigation and adaptation plan. The outcomes of these meetings are reported to the Board members. In addition to fixed agendas, Committee members […]
Leia mais

b) Describe management's role in assessing and managing climate-related risks and opportunities.

In recent years, RD Saúde has advanced in the climate agenda and integrated it into routine scenario analyses and evaluations of factors that may impact the Company, either positively or negatively. The Risk Committee, which advises the Board, identifies, measures, and monitors climate-related risks and opportunities in coordination with business areas, and defines processes to […]
Leia mais

/ Strategy

a) Describe climate-related risks and opportunities the organization has identified over the short, medium, and long term.

With ESG practices integrated into our corporate strategy, we use the Corporate Risk Matrix to anticipate risks, identify opportunities, and ensure business continuity. Risks and opportunities are assessed based on quantitative and qualitative criteria and classified according to their likelihood of occurrence and business impact. This approach enables us to design effective responses to financial, […]
Leia mais

b) Describe the impacts of climate-related risks and opportunities on the organization’s businesses, strategy, and financial planning.

Risks and opportunities are reflected in our 2030 Commitments, which guide investment and financial decisions over the short, medium, and long term. Several areas of the Company, such as Engineering, Risk Management, and Operations, work together to implement mitigation actions, including projects for the development of sustainable low-emission products and services, fleet decarbonization, and more […]
Leia mais

c) Describe the resilience of the organization’s strategy, taking into consideration different climate-related scenarios, including a 2°C or lower scenario.

RD Saúde has developed a consistent mitigation and adaptation strategy that strengthens business resilience in the face of climate change: we maintain a high percentage of electricity consumption from renewable sources and have implemented energy efficiency solutions; we invest in training our drivers and optimizing processes to increase vehicle efficiency; we expanded the volume of […]
Leia mais

/ Risk management

a) Describe the organization's processes for identifying and assessing climate-related risks.

To ensure a structured, science-based approach, in 2024 we conducted a detailed climate risk assessment covering all our operational assets, including the RD Saúde Campus, 14 Distribution Centers, and 3,230 pharmacies. Physical and transition risks were mapped in collaboration with business areas, analyzed by impact and likelihood of occurrence, and classified according to the Company’s […]
Leia mais

b) Describe the organization's processes for managing climate-related risks.

The review and monitoring of RD Saúde’s risks (including climate risks) are primarily conducted by the Risk Management Committee, an advisory body to the Executive Board, which holds regular meetings specifically to monitor risks according to their nature. This phase includes monitoring key risk indicators (KRIs), tracking the progress of previously defined action plans, and […]
Leia mais

c) Describe how processes for identifying, assessing and managing climate-related risks are integrated into the organization's overall risk management.

Since 2022, we have incorporated climate risks into the Company’s overall risk matrix. The Risk Management team ensures ongoing alignment with the Sustainability Department and with business areas directly involved in addressing and monitoring climate risks.
Leia mais

/ Metrics and targets

a) Disclose the metrics used by the organization to assess climate-related risks and opportunities in line with its strategy and risk managment process.

With ESG practices integrated into our corporate strategy, we use the Corporate Risk Matrix to anticipate risks, identify opportunities, and ensure business continuity. Risks and opportunities are assessed using quantitative and qualitative criteria and classified according to likelihood of occurrence and business impact. This approach enables effective responses to financial, reputational, operational, regulatory compliance, health […]
Leia mais

b) Disclose Scope 1, Scope 2 and, if appropriate, Scope 3 greenhouse gas (GHG) emissions and the related risks.

Our emissions can be consulted in GRI indicators 305-1, 305-2, and 305-3. Associated GHG risks include: Transition risks: carbon pricing, fossil fuel costs, exposure to climate litigation, noncompliance with climate-related financial disclosure requirements, noncompliance with emission disclosure requirements, liability for actions by suppliers and/or service providers without climate and ESG targets, and pressure to adopt […]
Leia mais

c) Describe the targets used by the organization to manage climate-related risks and opportunities and performance against targets.

In 2023, we revisited our 2030 sustainability commitments and updated our climate-related goals. We committed to: In addition, in 2024 we also achieved the following targets: supply 100% of operations with renewable energy and develop a tactical decarbonization plan for the Transportation area—both tied to the variable compensation of all corporate professionals, with greater weight […]
Leia mais
© 2025 RaiaDrogasil – Todos os direitos reservados. Produzido por Plank